SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.89p
   
  • Change Today:
      0.14p
  • 52 Week High: 29.00p
  • 52 Week Low: 7.25p
  • Currency: UK Pounds
  • Shares Issued: 202.26m
  • Volume: 506,635
  • Market Cap: £19.99m

Regulatory News

Extension of Croda contract for SkinBiotixâ... 19-Oct-2023 07:00 RNS
health authority approval for AxisBiotix in France 15-Sep-2023 09:00 RNS
Update on acne programme 05-Sep-2023 07:00 RNS
Holding(s) in Company 31-Jul-2023 12:51 RNS
Regulatory Approval 21-Jun-2023 07:00 RNS
Business progress update 14-Jun-2023 16:46 RNS
SkinBiotix and AxisBiotix Update 10-May-2023 07:00 RNS
Director/PDMR Shareholding 14-Apr-2023 07:00 RNS
Replacement Half-year Report 28-Mar-2023 13:45 RNS
Half-year Report 28-Mar-2023 07:00 RNS
Price Monitoring Extension 27-Mar-2023 16:35 RNS
Director/PDMR Shareholding 09-Mar-2023 17:18 RNS
Director/PDMR Shareholding 09-Mar-2023 17:18 RNS
AxisBiotix-Ps™ approved for launch in Europe 07-Mar-2023 07:00 RNS
Holding(s) in Company 20-Feb-2023 11:17 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 9.89p
Change Today 0.14p
% Change 1.38 %
52 Week High 29.00p
52 Week Low 7.25p
Volume 506,635
Shares Issued 202.26m
Market Cap £19.99m

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.13% below the market average71.13% below the market average71.13% below the market average71.13% below the market average71.13% below the market average
80.39% below the sector average80.39% below the sector average80.39% below the sector average80.39% below the sector average80.39% below the sector average
Price Trend
72.59% below the market average72.59% below the market average72.59% below the market average72.59% below the market average72.59% below the market average
5.66% below the sector average5.66% below the sector average5.66% below the sector average5.66% below the sector average5.66% below the sector average
Income Not Available
Growth
18.83% above the market average18.83% above the market average18.83% above the market average18.83% above the market average18.83% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

SBTX Dividends

No dividends found

Trades for 18-Jun-2024

Time Volume / Share Price
11:44 31,000 @ 9.60p
11:44 31,000 @ 9.50p
11:38 35,000 @ 9.57p
11:38 35,000 @ 9.50p
09:38 100,000 @ 9.52p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page